Page 13 - AN-4-1

Advanced Neurology Improving cognitive development in Down syndrome

doi: 10.1371/journal.pone.0215368.2019 regulator of neuronal development. FEBS J. 2010;278:
223-235.
5. Gray K, Wilkins-Haug L. Have we done our last
amniocentesis? Updates on cell-free DNA for Down doi: 10.1111/j.1742-4658.2010.07954.x
syndrome screening. Pediatr Radiol. 2018;48:461-470.
17. Chapman L, Ramnarine I, Zemke D, et al. Gene expression
doi: 10.1007/s00247-017-3958-y studies in Down syndrome: What do they tell us about
6. De Graaf G, Buckley F, Skotko B. Estimation of the number disease phenotypes? Int J Mol Sci. 2024;25:2968.
of people with Down syndrome in Europe. Europ J Hum doi: 10.3390/ijms25052968
Gen. 2021;29:402-410.
18. Guedj F, Sébrié C, Rivals I, et al. Green tea polyphenols
doi: 10.1038/s41431-020-00748-y rescue of brain defects induced by overexpression of
DYRK1A. PLoS One. 2009;4:e4606.
7. De Graaf G, Buckley F, Skotko B. Estimation of the number
of people with Down syndrome in the United States. Gen doi: 10.1371/journal.pone.0004606
Med. 2016;201:439-447.
19. Stagni F, Giacomini A, Emili M, et al. Short-and long-term
doi: 10.1038/gim.216.127 effects of neonatal pharmacotherapy with epigallocatechin-
8. O’Leary L, Cooper S, McCormack H. Early death and causes 3-gallate on hippocampal development in the Ts65Dn mouse
of death of people with Down syndrome: A systematic model of down syndrome. Neuroscience. 2016;333:277-301.
review. J Appl Res Intellect Disabil. 2018;31:325-342. doi: 10.1016/j.neuroscience.2016.07.031
doi: 10.1111/jar.12417 20. Starbuck J, llambrich S, Gonzales R, et al. Green tea extracts
9. Abukhaled Y, Hatab K, Awadhalla M, et al. Understanding containing epigallocatechin-3-gallate modulate facial
the genetic mechanisms and cognitive impairments in development in Down syndrome. Sci Rep. 2021;11:4715.
Down syndrome: Towards a holistic approach. J Neurol. doi: 10.1038/s41598-021-83757-1
2024;271:87-104.
21. De la Torre R, De Sola S, Hernandez G, et al. Safety and
doi: 10.1007/s00415-023-11890-0 efficacy of cognitive training plus epigallocatechin-3-
10. Amano T, Jeffries E, Amano M, Ko AC, Yu H, Ko MS. gallate in young adults with Down’s syndrome (TESDAD):
Correction of down syndrome and edwards syndrome A double-blind, randomized, placebo-controlled, phase 2
aneuploidies in human cell cultures. DNA Res. 2015;22: trial. Lancet Neurol. 2016;15:801-810.
331-342. doi: 10.1016/S1474-4422(16)30034-5
doi: 10.1093/dnares/dsv016 22. Prandini P, Deutsch S, Lyle R, et al. Natural gene-expression
11. Li L, Chang K, Wang P, et al. Trisomy correction in Down variation in Down syndrome modulates the outcome of
syndrome induced pluripotent stem cells. Cell Stem Cell. gene dosage imbalance. Am J Hum Genet. 2007;81:252-263.
2012;11:615-619. doi: 10.1086/519248
doi: 10.1016/j.stem.2012.08.004 23. Hunter S, Hendrix J, Freeman J, Allen MA. Transcription
12. Jiang J, Jing Y, Cost G, et al. Translating dosage compensation dosage compensation does not occur in Down syndrome.
to trisomy 21. Nature. 2013;500:296-300. BMC Biol. 2023;21:228.
doi: 10.1038/nature12394 doi: 10.1186/s12915-023-01700-4
13. Czerminsky J, Lawrence J. Silencing trisomy 21 with XIST 24. Donovan M, Eduthan N, Smith K, et al. Variegated
in neural stem cells promotes neuronal differentiation. Dev overexpression of chromosome 21 genes reveals molecular
Cell. 2020;52:294-308. and immune subtypes of down syndrome. Nat Com.
2024;15:5473.
doi: 10.1016/j.devcel.2019.12.015
doi: 10.1038/s41467-024-49781-1
14. Dumont M. Qualité et sélection des embryons. J Gynécol
Obstét Biol Reprod. 2008;17:S9-S13. 25. Takashima S, Iida K, Mito T, Arima M. Dendritic and
histochemical development and ageing in patients with
doi: 10.1016/S0368-2315(08)73844-4 Down’s syndrome. J Intellect Disabil Res. 1994;3:265-273.
15. Aït Yahya-Graison E, Aubert J, Dauphinot L, et al. doi: 10.1111/j.1365-2788.1994.tb00394.x
Classification of human chromosome 21 gene-expression
variations in Down syndrome: Impact on disease 26. Qiu JJ, Liu YN, Wey H, Zeng F, Yan JB. Single-cell RNA
phenotypes. Am J Hum Genet. 2007;81:475-491. sequencing of neural stem cells derived from human
trisomic iPSCs reveals the abnormalities during neural
doi: 10.1086/520000
differentiation of down syndrome. Front Mol Neurosci.
16. Tejedor F, Hammerle B. MNB/DYRK1A as a multiple 2023;16:1137.

Volume 4 Issue 1 (2025) 7 doi: 10.36922/an.3785